Rappaport S H, Shpiner R, Yoshihara G, Wright J, Chang P, Abraham E
Department of Medicine, UCLA School of Medicine.
Crit Care Med. 1994 Jan;22(1):22-32. doi: 10.1097/00003246-199401000-00009.
Volume-controlled ventilation is frequently chosen as the initial mode of ventilatory support in patients with hypoxic respiratory failure. Recent data, however, suggest that pressure-limited ventilation, using a rapidly decelerating flow delivery pattern, may produce a more desirable clinical effect through reduced peak airway pressures and increased static compliance, tissue oxygen delivery, and consumption. This study was performed to assess the feasibility and utility of early and sustained use of pressure-limited ventilation in patients with this clinical syndrome.
Randomized, prospective trial.
Medical intensive care unit (ICU) of a university hospital.
The study encompassed all patients (n = 27) receiving care in a medical ICU for acute, severe hypoxic respiratory failure (PaO2/FIO2 ratio of < 150) during a 6-month period.
Ventilatory support via either pressure-limited or volume-controlled ventilation, initiated within 24 hrs of endotracheal intubation.
On-line monitoring of the following ten ventilatory variables at 1-min intervals for 72 hrs or until extubation or death (maximum of 43,200 data points per patient): peak airway pressure, mean airway pressure, end-tidal CO2 concentration, CO2 minute excretion, inspiratory tidal volume, expiratory tidal volume, pause pressure, end-expiratory pressure, static thoracic compliance, and inspiratory resistance. Additionally, PaO2/FIO2 values and Acute Physiology and Chronic Health Evaluation (APACHE) II scores were recorded on a daily basis, as were significant clinical events and changes in ventilator settings.
Although the severity of illness at study entry as determined by APACHE II score and PaO2/FIO2 was similar in patients treated with pressure-limited or volume-controlled ventilation, peak airway pressure was consistently lower in patients randomized to pressure-limited ventilation (p = .05 at 12 hrs postintubation). The use of pressure-limited ventilation also was associated with a more rapid increase in static compliance (p = .05) than that found with volume-controlled ventilation. There was a trend toward more rapid normalization of CO2 minute excretion in patients treated with pressure-limited ventilation. Pressure-limited treated patients who survived their illness and were extubated, required fewer days of mechanical ventilation than did patients randomized to volume-controlled treated ventilation (p = .05). No pneumothoraces occurred in any study patients. One volume-controlled patient developed subcutaneous emphysema. Pressure-limited ventilation was well tolerated, and sedation requirements were equivalent in the two groups.
Pressure-limited ventilation can be used safely and is well tolerated as an initial mode of ventilatory support in patients with acute hypoxic respiratory failure. Because the early initiation of pressure-limited ventilation is associated with lower peak airway pressure and more rapid improvement in static thoracic compliance than volume-controlled ventilation, pressure-limited ventilation may have a beneficial role when used as the primary ventilatory modality in patients with this clinical condition.
在低氧性呼吸衰竭患者中,容量控制通气常被选作初始通气支持模式。然而,近期数据表明,采用快速减速气流输送模式的压力限制通气,可能通过降低气道峰压、增加静态顺应性、组织氧输送和氧消耗,产生更理想的临床效果。本研究旨在评估在该临床综合征患者中早期且持续使用压力限制通气的可行性和效用。
随机、前瞻性试验。
大学医院的医学重症监护病房(ICU)。
本研究纳入了在6个月期间因急性、严重低氧性呼吸衰竭(动脉血氧分压/吸入氧分数值<150)在医学ICU接受治疗的所有患者(n = 27)。
在气管插管后24小时内,通过压力限制通气或容量控制通气进行通气支持。
以1分钟的间隔对以下十个通气变量进行72小时的在线监测,或直至拔管或死亡(每位患者最多43,200个数据点):气道峰压、平均气道压、呼气末二氧化碳浓度、二氧化碳分钟排出量、吸气潮气量、呼气潮气量、平台压、呼气末压力、静态胸廓顺应性和吸气阻力。此外,每天记录动脉血氧分压/吸入氧分数值和急性生理与慢性健康状况评分(APACHE II),以及重大临床事件和通气设置的变化。
尽管通过APACHE II评分和动脉血氧分压/吸入氧分数值确定的研究入组时疾病严重程度在接受压力限制通气或容量控制通气治疗的患者中相似,但随机接受压力限制通气的患者气道峰压始终较低(插管后12小时时p = 0.05)。与容量控制通气相比,压力限制通气的使用还与静态顺应性更快增加相关(p = 0.05)。接受压力限制通气治疗的患者二氧化碳分钟排出量有更快恢复正常的趋势。存活并拔管的接受压力限制通气治疗的患者,其机械通气天数少于随机接受容量控制通气治疗的患者(p = 0.05)。任何研究患者均未发生气胸。一名接受容量控制通气的患者发生了皮下气肿。压力限制通气耐受性良好,两组的镇静需求相当。
压力限制通气作为急性低氧性呼吸衰竭患者的初始通气支持模式可安全使用且耐受性良好。由于与容量控制通气相比,早期启动压力限制通气与更低的气道峰压和更快改善静态胸廓顺应性相关,因此压力限制通气在作为该临床状况患者的主要通气方式使用时可能具有有益作用。